We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Artificial intelligence and generative AI
- Computing power and generative AI
- The philosophy of generative AI
- Traditional AI vs. generative AI
- Misconceptions vs. reality
- Comparison of failure rates before and after AI intervention
- Databases used by AI
- Target specific drugs using AI
- AI role (e.g., AlphaFold) in target identification and validation steps
- Lead optimization
- AI improvement (insilico medicine) in drug design and validation steps
- Al & ML in clinical trials
- AI improvement (AiCure) in clinical efficacy testing steps
- Benefits of automation in pharmacovigilance
- AI improvement in post-approval evaluation steps
- AI improvement (BenevolentAI) in drug repurposing steps
- AI/ML regulatory guidance timeline
- AI improvement (FDA/EMA) in regulatory compliance steps
- AI can significantly reduce the costs of drug development
- Drug candidates and AI contribution
- Courses in AI for drug discovery and development
- AI market
- Can generative AI catchup with brain?
- Financial disclosures
Topics Covered
- Artificial intelligence (AI)
- Generative AI
- Databases used by AI
- AI role in drug discovery and development
- AI market
- Can generative AI catchup with brain?
Talk Citation
Niazi, S.K. (2026, April 30). Generative AI in drug development: balancing innovation with human insight [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 30, 2026, from https://doi.org/10.69645/AREZ8677.Export Citation (RIS)
Publication History
- Published on April 30, 2026
Financial Disclosures
- Ownership of equity in companies engaged in novel drug research; multiple instances of compensated consulting.
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everybody. I'm pleased to
be invited to give you a talk on
a topic which is so
relevant today and so
talked about today;
Generative AI in
drug development.
I'm Sarfaraz Niazi.
I'm adjunct professor at
University of Illinois.
Been teaching all
my life in Chicago.
I have diversified
into many areas,
written several books
on this subject,
and I'm very pleased
to provide you
literally a summary of where do
we stand with generative AI.
0:42
Generative AI is a word
that has become literally
a household word especially
in the media and in the
scientific literature,
but one has to understand
what this technology does.
How it affects or how it
changes the development
of drugs is one of the most
significant application.
It takes billions of dollars
to develop a new drug,
and generative AI can not
only cut the cost down,
but more importantly,
cut the time down so
the drugs can reach
to patients sooner.
Generative AI, if
you look at it,
it's the last part of the train.
First you start with
artificial intelligence.
By the way, in reality
this is not artificial.
The intelligence is real,
but it's developed by a machine.
A better word maybe
adaptive intelligence,
but I'm not arguing
with that because
that's accepted terminology.
Machine learning.
How do you teach a machine?
In the case of
today's computers,
machine learning is simply
the memory kept there
and memory accessed.
Think of this way. You have
read every book in the universe,
you remember every word,
and at any single point,
you can gather all the
information together.
That's the intelligence that
we're talking about here.
That was never possible before
until the modern range
of computers came in.
Neural network is
almost like your brain.
When you are thinking
of your neurons,
you split the message across
many areas and then bring
back the information.
Think of this way.
The computers now are
working as if they
have a brain cells.
Deep learning is a machine
learning combined with
neural networks to learn
and extract the features.
It's not just a paragraph
that you have read.
But if you have
read 10 paragraphs,
can you consolidate them
which leads to the
generative AI,
which is basically
the term says,
you are creating a new content.
It could be images. It could
be an article you write.
It could be a theory,
whatever it is.
That is the base definition.
I wanted to share with you how